Global Biodefense Market Size, Status and Forecast 2023

Report ID: 1234903 | Published Date: Oct 2024 | No. of Page: 115 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biodefense Market Size Growth Rate by Type (2021-2027)
        1.2.2 Anthrax
        1.2.3 Smallpox
        1.2.4 Botulism
        1.2.5 Radiation/Nuclear
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Biodefense Market Share by Application (2021-2027)
        1.3.2 US Military Market
        1.3.3 US Civilian Market
        1.3.4 Non - US Market
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Biodefense Market Size
     2.2 Biodefense Market Size by Regions
        2.2.1 Biodefense Growth Rate by Regions (2021-2027)
        2.2.2 Biodefense Market Share by Regions (2021-2027)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Use Cases

3 Key Players
    3.1 Biodefense Revenue by Players (2020-2021)
    3.2 Biodefense Key Players Headquaters and Area Served
    3.3 Key Players Biodefense Product/Solution/Service
    3.4 Date of Enter into Biodefense Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
    4.1 Global Biodefense Market Size by Type (2021-2027)
    4.2 Global Biodefense Market Size by Application (2021-2027)

5 North America
   5.1 North America Biodefense Market Forecast (2021-2027)
    5.2 Biodefense Key Players in North America
    5.3 North America Biodefense Market Size by Type
    5.4 North America Biodefense Market Size by Application
        6.4.4 Canada

6 Europe
    6.1 Europe Biodefense Market Forecast (2021-2027)
    6.2 Biodefense Key Players in Europe
    6.3 Europe Biodefense Market Size by Type
    6.4 Europe Biodefense Market Size by Application

7 Japan
    7.1 Japan Biodefense Market Forecast (2021-2027)
    7.2 Biodefense Key Players in Europe
    7.3 Japan Biodefense Market Size by Type
    7.4 Japan Biodefense Market Size by Application

8 Rest of World
    8.1 China
        8.1.1 China Biodefense Market Analysis
        8.1.2 Key Players in China
    8.2 Southeast Asia
        8.2.1 Southeast Asia Biodefense Market Analysis
        8.2.2 Key Players in Southeast Asia
    8.3 India
        8.3.1 India Biodefense Market Analysis
        8.3.2 Key Players in India


9 International Player Profiles
    9.1 Emergent Biosolutions
        9.1.1 Emergent Biosolutions Company Details
        9.1.2 Emergent Biosolutions Description and Business Overview
        9.1.3 Emergent Biosolutions Biodefense Introduction
        9.1.4 Emergent Biosolutions Revenue in Biodefense Business (2020-2021)
        9.1.5 Emergent Biosolutions Recent Development
    9.2 Hytest
        9.2.1 Hytest Company Details
        9.2.2 Hytest Description and Business Overview
        9.2.3 Hytest Biodefense Introduction
        9.2.4 Hytest Revenue in Biodefense Business (2020-2021)
        9.2.5 Hytest Recent Development
    9.3 GSK
        9.3.1 GSK Company Details
        9.3.2 GSK Description and Business Overview
        9.3.3 GSK Biodefense Introduction
        9.3.4 GSK Revenue in Biodefense Business (2020-2021)
        9.3.5 GSK Recent Development
    9.4 Sanofi
        9.4.1 Sanofi Company Details
        9.4.2 Sanofi Description and Business Overview
        9.4.3 Sanofi Biodefense Introduction
        9.4.4 Sanofi Revenue in Biodefense Business (2020-2021)
        9.4.5 Sanofi Recent Development
    9.5 PharmAthene
        9.5.1 PharmAthene Company Details
        9.5.2 PharmAthene Description and Business Overview
        9.5.3 PharmAthene Biodefense Introduction
        9.5.4 PharmAthene Revenue in Biodefense Business (2020-2021)
        9.5.5 PharmAthene Recent Development
    9.6 Bavarian Nordic
        9.6.1 Bavarian Nordic Company Details
        9.6.2 Bavarian Nordic Description and Business Overview
        9.6.3 Bavarian Nordic Biodefense Introduction
        9.6.4 Bavarian Nordic Revenue in Biodefense Business (2020-2021)
        9.6.5 Bavarian Nordic Recent Development
    9.7 SIGA Technologies
        9.7.1 SIGA Technologies Company Details
        9.7.2 SIGA Technologies Description and Business Overview
        9.7.3 SIGA Technologies Biodefense Introduction
        9.7.4 SIGA Technologies Revenue in Biodefense Business (2020-2021)
        9.7.5 SIGA Technologies Recent Development
    9.8 Arbutus Biopharma
        9.8.1 Arbutus Biopharma Company Details
        9.8.2 Arbutus Biopharma Description and Business Overview
        9.8.3 Arbutus Biopharma Biodefense Introduction
        9.8.4 Arbutus Biopharma Revenue in Biodefense Business (2020-2021)
        9.8.5 Arbutus Biopharma Recent Development
    9.9 DynPort Vaccine
        9.9.1 DynPort Vaccine Company Details
        9.9.2 DynPort Vaccine Description and Business Overview
        9.9.3 DynPort Vaccine Biodefense Introduction
        9.9.4 DynPort Vaccine Revenue in Biodefense Business (2020-2021)
        9.9.5 DynPort Vaccine Recent Development
    9.10 Xoma Corporation
        9.10.1 Xoma Corporation Company Details
        9.10.2 Xoma Corporation Description and Business Overview
        9.10.3 Xoma Corporation Biodefense Introduction
        9.10.4 Xoma Corporation Revenue in Biodefense Business (2020-2021)
        9.10.5 Xoma Corporation Recent Development
    9.11 Ichor Medical Systems
        9.11.1 Ichor Medical Systems Company Details
        9.11.2 Ichor Medical Systems Description and Business Overview
        9.11.3 Ichor Medical Systems Biodefense Introduction
        9.11.4 Ichor Medical Systems Revenue in Biodefense Business (2020-2021)
        9.11.5 Ichor Medical Systems Recent Development
    9.12 Aeolus Pharmaceuticals
        9.12.1 Aeolus Pharmaceuticals Company Details
        9.12.2 Aeolus Pharmaceuticals Description and Business Overview
        9.12.3 Aeolus Pharmaceuticals Biodefense Introduction
        9.12.4 Aeolus Pharmaceuticals Revenue in Biodefense Business (2020-2021)
        9.12.5 Aeolus Pharmaceuticals Recent Development
    9.13 Achaogen
        9.13.1 Achaogen Company Details
        9.13.2 Achaogen Description and Business Overview
        9.13.3 Achaogen Biodefense Introduction
        9.13.4 Achaogen Revenue in Biodefense Business (2020-2021)
        9.13.5 Achaogen Recent Development
    9.14 Elusys Therapeutics
        9.14.1 Elusys Therapeutics Company Details
        9.14.2 Elusys Therapeutics Description and Business Overview
        9.14.3 Elusys Therapeutics Biodefense Introduction
        9.14.4 Elusys Therapeutics Revenue in Biodefense Business (2020-2021)
        9.14.5 Elusys Therapeutics Recent Development
    9.15 Dynavax Technologies
        9.15.1 Dynavax Technologies Company Details
        9.15.2 Dynavax Technologies Description and Business Overview
        9.15.3 Dynavax Technologies Biodefense Introduction
        9.15.4 Dynavax Technologies Revenue in Biodefense Business (2020-2021)
        9.15.5 Dynavax Technologies Recent Development
    9.16 Cleveland BioLabs
        9.16.1  Company Details
        9.16.2 Cleveland BioLabs Description and Business Overview
        9.16.3 Cleveland BioLabs Biodefense Introduction
        9.16.4 Cleveland BioLabs Revenue in Biodefense Business (2020-2021)
        9.16.5 Cleveland BioLabs Recent Development
    9.17 Soligenix
        9.17.1 Soligenix Company Details
        9.17.2 Soligenix Description and Business Overview
        9.17.3 Soligenix Biodefense Introduction
        9.17.4 Soligenix Revenue in Biodefense Business (2020-2021)
        9.17.5 Soligenix Recent Development
    9.18 Alnylam Pharmaceuticals
        9.18.1 Alnylam Pharmaceuticals Company Details
        9.18.2 Alnylam Pharmaceuticals Description and Business Overview
        9.18.3 Alnylam Pharmaceuticals Biodefense Introduction
        9.18.4 Alnylam Pharmaceuticals Revenue in Biodefense Business (2020-2021)
        9.18.5 Alnylam Pharmaceuticals Recent Development

10 Market Dynamics
    10.1 Industry Trends
    10.2 Market Drives
    10.3 Market Challenges
    10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
        12.1.2 Data Source
    12.2 Disclaimer
    12.3 Author Details
List of Tables
    Table 1. Global Biodefense Market Size Growth Rate by Type (2021-2027) (US$ Million)
    Table 2. Key Players of Anthrax
    Table 3. Key Players of Smallpox
    Table 4. Key Players of Botulism
    Table 5. Key Players of Radiation/Nuclear
    Table 6. Key Players of Others
    Table 7. Global Biodefense Market Size Growth by Application (2021-2027) (US$ Million)
    Table 8. Global Biodefense Market Size by Regions (2021-2027) (US$ Million)
    Table 9. Global Biodefense Market Share by Regions (2021-2027)
    Table 10. Market Top Trends
    Table 11. Market Use Cases
    Table 12. Global Biodefense Revenue by Players (2020-2021) (US$ Million)
    Table 13. Global Biodefense Market Share by Players (2020-2021)
    Table 14. Key Players Headquarters and Area Served
    Table 15. Key Players Biodefense Product Solution and Service
    Table 16. Date of Enter into Biodefense Market
    Table 17. Mergers & Acquisitions, Expansion Plans
    Table 18. Global Biodefense Market Size by Type (2021-2027) (US$ Million)
    Table 19. Global Biodefense Market Size Share by Type (2021-2027)
    Table 20. Global Biodefense Market Size by Application (2021-2027) (US$ Million)
    Table 21. Global Biodefense Market Size Share by Application (2021-2027)
    Table 22. North America Key Players Biodefense Revenue (2020-2021) (US$ Million)
    Table 23. North America Key Players Biodefense Market Share (2020-2021)
    Table 24. North America Biodefense Market Size by Type (2021-2027) (US$ Million)
    Table 25. North America Biodefense Market Share by Type (2021-2027)
    Table 26. North America Biodefense Market Size by Application (2021-2027) (US$ Million)
    Table 27. North America Biodefense Market Share by Application (2021-2027)
    Table 28. Europe Key Players Biodefense Revenue (2020-2021) (US$ Million)
    Table 29. Europe Key Players Biodefense Market Share (2020-2021)
    Table 30. Europe Biodefense Market Size by Type (2021-2027) (US$ Million)
    Table 31. Europe Biodefense Market Share by Type (2021-2027)
    Table 32. Europe Biodefense Market Size by Application (2021-2027) (US$ Million)
    Table 33. Europe Biodefense Market Share by Application (2021-2027)
    Table 34. Japan Key Players Biodefense Revenue (2020-2021) (US$ Million)
    Table 35. Japan Key Players Biodefense Market Share (2020-2021)
    Table 36. Japan Biodefense Market Size by Type (2021-2027) (US$ Million)
    Table 37. Japan Biodefense Market Share by Type (2021-2027)
    Table 38. Japan Biodefense Market Size by Application (2021-2027) (US$ Million)
    Table 39. Japan Biodefense Market Share by Application (2021-2027)
    Table 40. Key Players in China
    Table 41. Key Players in Southeast Asia
    Table 42. Key Players in India
    Table 43. Emergent Biosolutions Company Details
    Table 44. Emergent Biosolutions Description and Business Overview
    Table 45. Emergent Biosolutions Biodefense Product
    Table 46. Emergent Biosolutions Revenue in Biodefense Business 2020 and 2021
    Table 47. Emergent Biosolutions Recent Development
    Table 48. Hytest Company Details
    Table 49. Hytest Description and Business Overview
    Table 50. Hytest Biodefense Product
    Table 51. Hytest Revenue in Biodefense Business 2020 and 2021
    Table 52. Hytest Recent Development
    Table 53. GSK Company Details
    Table 54. GSK Description and Business Overview
    Table 55. GSK Biodefense Product
    Table 56. GSK Revenue in Biodefense Business 2020 and 2021
    Table 57. GSK Recent Development
    Table 58. Sanofi Company Details
    Table 59. Sanofi Description and Business Overview
    Table 60. Sanofi Biodefense Product
    Table 61. Sanofi Revenue in Biodefense Business 2020 and 2021
    Table 62. Sanofi Recent Development
    Table 63. PharmAthene Company Details
    Table 64. PharmAthene Description and Business Overview
    Table 65. PharmAthene Biodefense Product
    Table 66. PharmAthene Revenue in Biodefense Business 2020 and 2021
    Table 67. PharmAthene Recent Development
    Table 68. Bavarian Nordic Company Details
    Table 69. Bavarian Nordic Description and Business Overview
    Table 70. Bavarian Nordic Biodefense Product
    Table 71. Bavarian Nordic Revenue in Biodefense Business 2020 and 2021
    Table 72. Bavarian Nordic Recent Development
    Table 73. SIGA Technologies Company Details
    Table 74. SIGA Technologies Description and Business Overview
    Table 75. SIGA Technologies Biodefense Product
    Table 76. SIGA Technologies Revenue in Biodefense Business 2020 and 2021
    Table 77. SIGA Technologies Recent Development
    Table 78. Arbutus Biopharma Company Details
    Table 79. Arbutus Biopharma Description and Business Overview
    Table 80. Arbutus Biopharma Biodefense Product
    Table 81. Arbutus Biopharma Revenue in Biodefense Business 2020 and 2021
    Table 82. Arbutus Biopharma Recent Development
    Table 83. DynPort Vaccine Company Details
    Table 84. DynPort Vaccine Description and Business Overview
    Table 85. DynPort Vaccine Biodefense Product
    Table 86. DynPort Vaccine Revenue in Biodefense Business 2020 and 2021
    Table 87. DynPort Vaccine Recent Development
    Table 88. Xoma Corporation Company Details
    Table 89. Xoma Corporation Description and Business Overview
    Table 90. Xoma Corporation Biodefense Product
    Table 91. Xoma Corporation Revenue in Biodefense Business 2020 and 2021
    Table 92. Xoma Corporation Recent Development
    Table 93. Ichor Medical Systems Company Details
    Table 94. Ichor Medical Systems Description and Business Overview
    Table 95. Ichor Medical Systems Biodefense Product
    Table 96. Ichor Medical Systems Revenue in Biodefense Business 2020 and 2021
    Table 97. Ichor Medical Systems Recent Development
    Table 98. Aeolus Pharmaceuticals Company Details
    Table 99. Aeolus Pharmaceuticals Description and Business Overview
    Table 100. Aeolus Pharmaceuticals Biodefense Product
    Table 101. Aeolus Pharmaceuticals Revenue in Biodefense Business 2020 and 2021
    Table 102. Aeolus Pharmaceuticals Recent Development
    Table 103. Achaogen Company Details
    Table 104. Achaogen Description and Business Overview
    Table 105. Achaogen Biodefense Product
    Table 106. Achaogen Revenue in Biodefense Business 2020 and 2021
    Table 107. Achaogen Recent Development
    Table 108. Elusys Therapeutics Company Details
    Table 109. Elusys Therapeutics Description and Business Overview
    Table 110. Elusys Therapeutics Biodefense Product
    Table 111. Elusys Therapeutics Revenue in Biodefense Business 2020 and 2021
    Table 112. Elusys Therapeutics Recent Development
    Table 113. Dynavax Technologies Company Details
    Table 114. Dynavax Technologies Description and Business Overview
    Table 115. Dynavax Technologies Biodefense Product
    Table 116. Dynavax Technologies Revenue in Biodefense Business 2020 and 2021
    Table 117. Dynavax Technologies Recent Development
    Table 118. Cleveland BioLabs Company Details
    Table 119. Cleveland BioLabs Description and Business Overview
    Table 120. Cleveland BioLabs Biodefense Product
    Table 121. Cleveland BioLabs Revenue in Biodefense Business 2020 and 2021
    Table 122. Cleveland BioLabs Recent Development
    Table 123. Soligenix Company Details
    Table 124. Soligenix Description and Business Overview
    Table 125. Soligenix Biodefense Product
    Table 126. Soligenix Revenue in Biodefense Business 2020 and 2021
    Table 127. Soligenix Recent Development
    Table 128. Alnylam Pharmaceuticals Company Details
    Table 129. Alnylam Pharmaceuticals Description and Business Overview
    Table 130. Alnylam Pharmaceuticals Biodefense Product
    Table 131. Alnylam Pharmaceuticals Revenue in Biodefense Business 2020 and 2021
    Table 132. Alnylam Pharmaceuticals Recent Development
    Table 133. Biodefense Market Trends
    Table 134. Biodefense Market Drivers
    Table 135. Biodefense Market Challenges
    Table 136. Biodefense Market Restraints
    Table 137. Research Programs/Design for This Report
    Table 138. Key Data Information from Secondary Sources
    Table 139. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biodefense Market Share by Type in 2021 & 2027
    Figure 2. Anthrax Features
    Figure 3. Smallpox Features
    Figure 4. Botulism Features
    Figure 5. Radiation/Nuclear Features
    Figure 6. Others Features
    Figure 7. Global Biodefense Market Share by Application in 2021 & 2027
    Figure 8. US Military Market Case Studies
    Figure 9. US Civilian Market Case Studies
    Figure 10. Non - US Market Case Studies
    Figure 11. Biodefense Report Years Considered
    Figure 12. Global Biodefense Market Size and Growth Rate (2020-2027) (US$ Million)
    Figure 13. Global Biodefense Market Share by Regions (2020-2027)
    Figure 14. Global Biodefense Market Share by Players in 2021
    Figure 15. Global Biodefense Market Size Market Share by Type (2021-2027)
    Figure 16. Global Biodefense Market Size Market Share by Application (2021-2027)
    Figure 17. Global Biodefense Revenue Market Share by Application in 2021
    Figure 18. North America Biodefense Market Size 2021-2027 (US$ Million)
    Figure 19. Europe Biodefense Market Size 2021-2027 (US$ Million)
    Figure 20. Japan Biodefense Market Size 2021-2027 (US$ Million)
    Figure 21. Biodefense Market Size in China (2021-2027) (US$ Million)
    Figure 22. Biodefense Market Size in Southeast Asia (2021-2027) (US$ Million)
    Figure 23. Biodefense Market Size in India (2021-2027) (US$ Million)
    Figure 24. Bottom-up and Top-down Approaches for This Report
    Figure 25. Data Triangulation
    Figure 26. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Frequently Asked Questions
Biodefense report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biodefense report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biodefense report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Automotive Software

Automotive Software market is segmented by company, region (country), by Type, and by Application ... Read More